BlackRock’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-69,210
Closed -$2M 5760
2025
Q4
$2M Sell
69,210
-26,983
-28% -$512K ﹤0.01% 4115
2025
Q3
$746K Sell
96,193
-54,344
-36% -$408K ﹤0.01% 4376
2025
Q2
$1.11M Sell
150,537
-182,510
-55% -$1.6M ﹤0.01% 4215
2025
Q1
$2.87M Sell
333,047
-35,160
-10% -$543K ﹤0.01% 3878
2024
Q4
$13.2M Buy
368,207
+23,333
+7% +$1.21M ﹤0.01% 3279
2024
Q3
$16.3M Buy
344,874
+9,518
+3% +$420K ﹤0.01% 3166
2024
Q2
$16.9M Buy
335,356
+11,527
+4% +$833K ﹤0.01% 3082
2024
Q1
$36.3M Buy
323,829
+10,058
+3% +$1,000K ﹤0.01% 2638
2023
Q4
$18.2M Sell
313,771
-5,135
-2% -$207K ﹤0.01% 3063
2023
Q3
$10.1M Buy
318,906
+347
+0.1% +$16.5K ﹤0.01% 3325
2023
Q2
$26.2M Buy
318,559
+19,606
+7% +$2.87M ﹤0.01% 2870
2023
Q1
$30.7M Sell
298,953
-724
-0.2% -$102K ﹤0.01% 2742
2022
Q4
$43.9M Buy
299,677
+16,154
+6% +$2.73M ﹤0.01% 2563
2022
Q3
$47.9M Sell
283,523
-71,718
-20% -$11.7M ﹤0.01% 2465
2022
Q2
$41M Buy
355,241
+50,193
+16% +$4.72M ﹤0.01% 2624
2022
Q1
$30.4M Buy
305,048
+5,879
+2% +$687K ﹤0.01% 2903
2021
Q4
$46.5M Sell
299,169
-53,124
-15% -$10.3M ﹤0.01% 2702
2021
Q3
$83.1M Sell
352,293
-615
-0.2% -$180K ﹤0.01% 2334
2021
Q2
$120M Buy
352,908
+32,825
+10% +$12.4M ﹤0.01% 2144
2021
Q1
$129M Buy
320,083
+571
+0.2% +$277K ﹤0.01% 2032
2020
Q4
$213M Buy
319,512
+29,432
+10% +$16.4M 0.01% 1573
2020
Q3
$135M Buy
290,080
+4,570
+2% +$2.31M 0.01% 1689
2020
Q2
$167M Buy
285,510
+154,051
+117% +$52.6M 0.01% 1491
2020
Q1
$19.2M Buy
131,459
+32,846
+33% +$5.74M ﹤0.01% 2624
2019
Q4
$14.1M Buy
98,613
+1,343
+1% +$98.2K ﹤0.01% 3072
2019
Q3
$3.84M Buy
97,270
+1,651
+2% +$120K ﹤0.01% 3556
2019
Q2
$9.68M Buy
95,619
+59,705
+166% +$7.03M ﹤0.01% 3272
2019
Q1
$4.72M Buy
35,914
+4,669
+15% +$587K ﹤0.01% 3430
2018
Q4
$3.19M Sell
31,245
-9,757
-24% -$1.54M ﹤0.01% 3529
2018
Q3
$10.3M Buy
41,002
+748
+2% +$251K ﹤0.01% 3226
2018
Q2
$18M Buy
40,254
+7,534
+23% +$3.31M ﹤0.01% 2924
2018
Q1
$12.9M Buy
32,720
+9,628
+42% +$3.8M ﹤0.01% 2997
2017
Q4
$9.48M Buy
23,092
+12,541
+119% +$5.47M ﹤0.01% 3172
2017
Q3
$4.56M Buy
+10,551
New +$4.16M ﹤0.01% 3489

Other funds holding MRSN